{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:49:01Z","timestamp":1784033341051,"version":"3.55.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ccl.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T10:02:19Z","timestamp":1282903339000},"page":"675-691","source":"Crossref","is-referenced-by-count":34,"title":["Prevention, Diagnosis, and Treatment of Hypertensive Heart Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Vasiliki V.","family":"Georgiopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas P.","family":"Kalogeropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.HYP.0000093382.69464.C4","article-title":"Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values?","volume":"42","author":"Kannel","year":"2003","journal-title":"Hypertension"},{"issue":"9349","key":"10.1016\/j.ccl.2010.07.005_bib2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2010.07.005_bib3","author":"World Health Organization"},{"issue":"10","key":"10.1016\/j.ccl.2010.07.005_bib4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.CIR.103.10.1375","article-title":"Mechanotransduction in cardiomyocyte hypertrophy","volume":"103","author":"Sugden","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2004.11.004","article-title":"STRESS signaling pathways that modulate cardiac myocyte apoptosis","volume":"38","author":"Baines","year":"2005","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00001573-200007000-00010","article-title":"Fibrosis and hypertensive heart disease","volume":"15","author":"Weber","year":"2000","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"18","key":"10.1016\/j.ccl.2010.07.005_bib8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann Intern Med"},{"issue":"3 Pt 1","key":"10.1016\/j.ccl.2010.07.005_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-8703(85)90566-6","article-title":"Unrecognized myocardial infarction and hypertension: the Framingham Study","volume":"109","author":"Kannel","year":"1985","journal-title":"Am Heart J"},{"issue":"20","key":"10.1016\/j.ccl.2010.07.005_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccl.2010.07.005_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinternmed.2009.40","article-title":"Epidemiology of incident heart failure in a contemporary elderly cohort: the Health, Aging, And Body Composition study","volume":"169","author":"Kalogeropoulos","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2010.07.005_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCHEARTFAILURE.108.768457","article-title":"Incident heart failure prediction in the elderly: the health ABC heart failure score","volume":"1","author":"Butler","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"24","key":"10.1016\/j.ccl.2010.07.005_bib14","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2010.07.005_bib15","series-title":"Reducing risks, promoting healthy life","author":"World Health Report","year":"2002"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib16","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.CIR.63.6.1391","article-title":"Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings","volume":"63","author":"Reichek","year":"1981","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2010.07.005_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0735-1097(83)80167-3","article-title":"Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements","volume":"2","author":"Woythaler","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccl.2010.07.005_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0895-7061(02)02945-X","article-title":"Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint","volume":"15","author":"Okin","year":"2002","journal-title":"Am J Hypertens"},{"issue":"24","key":"10.1016\/j.ccl.2010.07.005_bib19","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1001\/jama.1992.03480240056034","article-title":"Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence","volume":"267","author":"Lee","year":"1992","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2010.07.005_bib22","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"10","key":"10.1016\/j.ccl.2010.07.005_bib23","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.echo.2005.04.012","article-title":"The accuracy of left ventricular mass determined by real-time three-dimensional echocardiography in chronic animal and clinical studies: a comparison with postmortem examination and magnetic resonance imaging","volume":"18","author":"Qin","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.ccl.2010.07.005_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.echo.2008.07.008","article-title":"Measurement of left ventricular mass by real-time three-dimensional echocardiography: validation against magnetic resonance and comparison with two-dimensional and m-mode measurements","volume":"21","author":"Takeuchi","year":"2008","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ahj.2005.02.018","article-title":"Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging\u2013the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"151","author":"Edvardsen","year":"2006","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ahj.2005.04.029","article-title":"Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance","volume":"151","author":"Raman","year":"2006","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02841850601067611","article-title":"Assessment of left ventricular function and mass in patients undergoing computed tomography (CT) coronary angiography using 64-detector-row CT: comparison to magnetic resonance imaging","volume":"48","author":"Schlosser","year":"2007","journal-title":"Acta Radiol"},{"issue":"8","key":"10.1016\/j.ccl.2010.07.005_bib29","first-page":"1288","article-title":"Comparison of 64-slice CT with gated SPECT for evaluation of left ventricular function","volume":"47","author":"Schepis","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ccl.2010.07.005_bib34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.288.15.1882","article-title":"Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program","volume":"288","author":"Whelton","year":"2002","journal-title":"JAMA"},{"issue":"8693","key":"10.1016\/j.ccl.2010.07.005_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib37","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0735-1097(95)00606-0","article-title":"Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials","volume":"27","author":"Moser","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9457","key":"10.1016\/j.ccl.2010.07.005_bib38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(05)17833-7","article-title":"Treatment with drugs to lower blood pressure and blood cholesterol based on an individual\u2019s absolute cardiovascular risk","volume":"365","author":"Jackson","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ccl.2010.07.005_bib39","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/hc4101.097520","article-title":"Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile","volume":"104","author":"Ferrucci","year":"2001","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ccl.2010.07.005_bib40","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccl.2010.07.005_bib41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1524-6175.2005.04769.x","article-title":"Expanding the definition and classification of hypertension","volume":"7","author":"Giles","year":"2005","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J\u00a0Hypertens"},{"issue":"18","key":"10.1016\/j.ccl.2010.07.005_bib43","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2010.07.005_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2007-2776","article-title":"Blood pressure variability and classification of prehypertension and hypertension in adolescence","volume":"122","author":"Falkner","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/eurpub\/14.3.235","article-title":"Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations","volume":"14","author":"Geleijnse","year":"2004","journal-title":"Eur J Public Health"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib46","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","article-title":"Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II","volume":"134","author":"Stevens","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jama.1984.03350040017014","article-title":"Physical fitness and incidence of hypertension in healthy normotensive men and women","volume":"252","author":"Blair","year":"1984","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ccl.2010.07.005_bib49","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A\u00a0clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.1997.00440270105009","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.161.5.685","article-title":"Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)","volume":"161","author":"Appel","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2010.07.005_bib53","series-title":"Dietary guidelines for Americans","year":"2005"},{"issue":"11","key":"10.1016\/j.ccl.2010.07.005_bib54","first-page":"281","article-title":"Application of lower sodium intake recommendations to adults\u2013United States, 1999\u20132006","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccl.2010.07.005_bib55","author":"American Heart Association"},{"issue":"1 Pt 2","key":"10.1016\/j.ccl.2010.07.005_bib56","first-page":"R30","article-title":"Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats","volume":"264","author":"Frohlich","year":"1993","journal-title":"Am J Physiol"},{"issue":"6 Pt 2","key":"10.1016\/j.ccl.2010.07.005_bib57","first-page":"H2103","article-title":"Influence of sodium intake on in vivo left ventricular anatomy in experimental renovascular hypertension","volume":"264","author":"de Simone","year":"1993","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0895-7061(95)00338-X","article-title":"Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition","volume":"9","author":"de Simone","year":"1996","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib59","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"9689","key":"10.1016\/j.ccl.2010.07.005_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.0954-6820.1980.tb09748.x","article-title":"The antihypertensive effect of prazosin on mild to moderate hypertension, changes in plasma volume, extracellular volume and glomerular filtration rate","volume":"207","author":"McNair","year":"1980","journal-title":"Acta Med Scand"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib62","doi-asserted-by":"crossref","first-page":"82G","DOI":"10.1016\/0002-9149(87)90163-9","article-title":"Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension","volume":"59","author":"Wilner","year":"1987","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2010.07.005_bib63","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HJH.0b013e3283013b44","article-title":"Effect of doxazosin on the left ventricular structure and function in morning hypertensive patients: the Japan Morning Surge 1 study","volume":"26","author":"Matsui","year":"2008","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A\u00a0meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"issue":"9311","key":"10.1016\/j.ccl.2010.07.005_bib65","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.fjc.0000193808.99773.28","article-title":"Losartan and prevention of atrial fibrillation recurrence in hypertensive patients","volume":"47","author":"Fogari","year":"2006","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/hy0102.100788","article-title":"Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II","volume":"39","author":"Gonzalez","year":"2002","journal-title":"Hypertension"},{"issue":"23","key":"10.1016\/j.ccl.2010.07.005_bib69","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2010.07.005_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002003.pub2","article-title":"Beta-blockers for hypertension","volume":"1","author":"Wiysonge","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.ccl.2010.07.005_bib71","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2008.05.057","article-title":"Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis","volume":"52","author":"Bangalore","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib72","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/eurheartj\/ehn575","article-title":"Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis","volume":"30","author":"Verdecchia","year":"2009","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ccl.2010.07.005_bib73","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib74","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2005.01.047","article-title":"Barriers to hypertension control","volume":"149","author":"Borzecki","year":"2005","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib76","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-147-5-200709040-00006","article-title":"Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients","volume":"147","author":"Okin","year":"2007","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.ccl.2010.07.005_bib78","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events","volume":"292","author":"Okin","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccl.2010.07.005_bib79","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2010.07.005_bib80","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ajh.2010.65","article-title":"Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients","volume":"23","author":"Okin","year":"2010","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib81","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.hjh.0000166852.18463.5e","article-title":"Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA)","volume":"23","author":"Agabiti-Rosei","year":"2005","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.jhh.1001708","article-title":"Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study","volume":"18","author":"Bella","year":"2004","journal-title":"J\u00a0Hum Hypertens"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib83","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/01.hjh.0000160222.17092.b8","article-title":"Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy","volume":"23","author":"Muller-Brunotte","year":"2005","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1016\/j.ccl.2010.07.005_bib84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004872-200102000-00018","article-title":"Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial","volume":"19","author":"Terpstra","year":"2001","journal-title":"J\u00a0Hypertens"},{"issue":"12","key":"10.1016\/j.ccl.2010.07.005_bib85","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ccl.2010.07.005_bib86","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib87","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.0000137118.47943.5C","article-title":"Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial","volume":"110","author":"Ciulla","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib88","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(99)00048-0","article-title":"Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise","volume":"33","author":"Warner","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2010.07.005_bib89","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0002-9149(90)90937-V","article-title":"Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance","volume":"66","author":"Setaro","year":"1990","journal-title":"Am J Cardiol"},{"issue":"9386","key":"10.1016\/j.ccl.2010.07.005_bib90","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib91","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ccl.2010.07.005_bib92","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ccl.2010.07.005_bib93","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ccl.2010.07.005_bib95","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib96","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib97","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccl.2010.07.005_bib98","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ccl.2010.07.005_bib99","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","article-title":"Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data","volume":"43","author":"Wong","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9386","key":"10.1016\/j.ccl.2010.07.005_bib100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ccl.2010.07.005_bib101","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2010.07.005_bib102","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCHEARTFAILURE.108.807032","article-title":"Digoxin therapy does not improve outcomes in\u00a0patients with advanced heart failure on contemporary medical therapy","volume":"2","author":"Georgiopoulou","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"24","key":"10.1016\/j.ccl.2010.07.005_bib103","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A\u00a0comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group","volume":"5","author":"Carson","year":"1999","journal-title":"J\u00a0Card Fail"},{"issue":"20","key":"10.1016\/j.ccl.2010.07.005_bib106","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccl.2010.07.005_bib107","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0735-1097(99)00148-5","article-title":"Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator","volume":"33","author":"Knight","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib108","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccl.2010.07.005_bib109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2010.07.005_bib110","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ccl.2010.07.005_bib111","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib112","first-page":"810","article-title":"Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials","volume":"44","author":"McAlister","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/CS20070193","article-title":"Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?","volume":"114","author":"Paterna","year":"2008","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.ccl.2010.07.005_bib114","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/euhj.1997.0736","article-title":"Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group","volume":"19","author":"Experience from controlled trials of physical training in chronic heart failure","year":"1998","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2010.07.005_bib115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mhj.2002.123310","article-title":"Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT)","volume":"144","author":"McKelvie","year":"2002","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2010.07.005_bib116","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0735-1097(94)00568-B","article-title":"Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles","volume":"25","author":"Hambrecht","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7433","key":"10.1016\/j.ccl.2010.07.005_bib117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.37938.645220.EE","article-title":"Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)","volume":"328","author":"Piepoli","year":"2004","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib118","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O\u2019Connor","year":"2009","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ccl.2010.07.005_bib119","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2010.07.005_bib120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"Fuster","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2010.07.005_bib121","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.jacc.2006.07.010","volume":"48","author":"Zipes","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ccl.2010.07.005_bib122","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865110000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865110000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T22:34:30Z","timestamp":1711751670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865110000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0733865110000858"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2010.07.005","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}